polyclonal antibodies (SAB Biotherapeutics)

N/A

Report date: 2025/01/26 15:36:42

Base Information

Drug Namepolyclonal antibodies (SAB Biotherapeutics)
Drug Alias NameSAB-123
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSab Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSab Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A